αααααβααΎαVRTX β’ NASDAQ
add
Vertex Pharmaceuticals Inc
493.84$
αααααααααα(0.0081%)-0.040
493.80$
ααΆααα·αα 25 ααααΆ, 4:51:48 PM ααααβααα -4 · USD · NASDAQ · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
ααΆαβα αα»αααΌααααααααααΆαα
α»ααααααΈαα
α’αΆαααα·αααΆαααΈααααΆααααΆααααααΆααα
α’αΆαααα·α
αα·αααΈαα»α
492.47$
α
αααααααααααα
484.50$ - 494.92$
α
ααααααα½αααααΆαα
α»αααααα
378.00$ - 519.88$
ααΎαβαα»αβααΈααααΆα
126.96Β αααΈααΆα USD
ααα ααα½αααΌαααααα
1.58Β ααΆα
α’αα»ααΆα P/E
-
αα·αααααβααΆαααΆα
-
ααΆααααααΌαα
αααα
NASDAQ
αααα»αβααααααΆαβ
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
| (USD) | ααααΌ 2024info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌα | 2.91Β αααΈααΆα | 15.66% |
α
αααΆαααααα·ααααα·ααΆα | 345.00Β ααΆα | -6.53% |
α
αααΌααα»ααα | 913.00Β ααΆα | -5.76% |
ααααΆααα
αααααα»ααα | 31.35 | -18.53% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | 3.98 | -5.24% |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | 1.33Β αααΈααΆα | 32.70% |
α’ααααΆαααααααααΆαααααα·αααααΆα | 19.67% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
| (USD) | ααααΌ 2024info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 6.12Β αααΈααΆα | -45.48% |
ααααααααα»α | 22.53Β αααΈααΆα | -0.87% |
ααΆαααα½ααα»αααααΌαααα»α | 6.12Β αααΈααΆα | 18.91% |
ααΌαβααααα»α | 16.41Β αααΈααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 256.79Β ααΆα | β |
ααααααααααΉαααααα
| 7.71 | β |
ααα
ααααααΎαααααα | 14.63% | β |
ααα
ααααααΎααΎααα»α | 18.42% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
| (USD) | ααααΌ 2024info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌααα»ααα | 913.00Β ααΆα | -5.76% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | 584.60Β ααΆα | 149.19% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | -821.90Β ααΆα | 7.29% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | -391.30Β ααΆα | -226.63% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | -675.90Β ααΆα | 9.19% |
ααα αΌαααΆα
αααααΆααααααα | 110.54Β ααΆα | -75.35% |
α’αααΈ
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
ααΆααααααΎαα‘αΎα
1989
ααΆαα·ααΆαααβαααααΆα
αααααβαααααΆα
αα»ααααα·α
6,100
